Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models
The DOI matches its Crossref record; 50 of the 52 references it cites were found in a registry or an index.
Abstract
Parkinson disease is a common neurodegenerative disorder that leads to difficulty in effectively translating thought into action. Although it is known that dopaminergic neurons that innervate the striatum die in Parkinson disease, it is not clear how this loss leads to symptoms. Recent work has implicated striatopallidal medium spiny neurons (MSNs) in this process, but how and precisely why these neurons change is not clear. Using multiphoton imaging, we show that dopamine depletion leads to a rapid and profound loss of spines and glutamatergic synapses on striatopallidal MSNs but not on neighboring striatonigral MSNs. This loss of connectivity is triggered by a new mechanism-dysregulation of intraspine Cav1.3 L-type Ca(2+) channels. The disconnection of striatopallidal neurons from motor command structures is likely to be a key step in the emergence of pathological activity that is responsible for symptoms in Parkinson disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, rats learning new motor skills have a greater number of synapses per neuron within the motor cortex, without an increase in capillary density.96, 103, 104”
From Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's disease (2013) · cites this paper as [96]
In the citing paper
“Exercise increases blood flow in the healthy brain in a wide range of animal species undergoing various exercise regimens 96, 97.”
From Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's disease (2013) · cites this paper as [96]
Citations
Cites
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R. (1990) · Science · doi:10.1126/science.2147780 · Cited by 2,967
Shrinkage of dendritic spines associated with long-term depression of hippocampal synapses
Zhou, Q., Homma, K. J., & Poo, M.-M. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.011 · Cited by 1,025
Synaptic organisation of the basal ganglia
BOLAM, J. P., HANLEY, J. J., BOOTH, P. A. C., & BEVAN, M. D. (2000) · Journal of Anatomy · doi:10.1046/j.1469-7580.2000.19640527.x · Cited by 948
Congenital Deafness and Sinoatrial Node Dysfunction in Mice Lacking Class D L-Type Ca2+ Channels
Platzer, J., Engel, J., Schrott-Fischer, A., Stephan, K., Bova, S., Chen, H., Zheng, H., & Striessnig, J. (2000) · Cell · doi:10.1016/s0092-8674(00)00013-1 · Cited by 932
Dolmetsch, R. E., Pajvani, U., Fife, K., Spotts, J. M., & Greenberg, M. E. (2001) · Science · doi:10.1126/science.1063395 · Cited by 900
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia
Picconi, B., Centonze, D., Håkansson, K., Bernardi, G., Greengard, P., Fisone, G., Cenci, M. A., & Calabresi, P. (2003) · Nature Neuroscience · doi:10.1038/nn1040 · Cited by 821
Homeostatic plasticity in neuronal networks: the more things change, the more they stay the same
Turrigiano, G. G. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01341-1 · Cited by 821
The origins of two-state spontaneous membrane potential fluctuations of neostriatal spiny neurons
Wilson, C., & Kawaguchi, Y. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-07-02397.1996 · Cited by 795
Coordinated Expression of Dopamine Receptors in Neostriatal Medium Spiny Neurons
Surmeier, D. J., Song, W.-J., & Yan, Z. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-20-06579.1996 · Cited by 747
Self-citation
Cited by
Items 201–300 of 746
Levodopa treatment: impacts and mechanisms throughout Parkinson’s disease progression
Riederer, P. F., Strobel, S., Nagatsu, T., Watanabe, H., Chen, X. M., Löschmann, P. A., Sian‐Hülsmann, J., Jost, W. H., Müller, T., Dijkstra, J. M., et al. (2025) · Journal of Neural Transmission · doi:10.1007/s00702-025-02893-4 · Cited by 126
“At a closer look, in a mouse PD model, only the D2 MSNs showed a loss of dendritic spines and glutamatergic synapses in response to DA depletion (Day et al. 2006).”
Homeostatic Plasticity of Striatal Neurons Intrinsic Excitability following Dopamine Depletion
Azdad, K., Chàvez, M., Bischop, P. D., Wetzelaer, P., Marescau, B., De Deyn, P. P., Gall, D., & Schiffmann, S. N. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006908 · Cited by 77
“This model could be considered as strongly reliable since it has been previously shown to lead to similar consequences on striatal physiology than the 6- hydroxydopamine (6-OHDA) model [7,14].”
BackgroundResultInfluentialNeurone specific regulation of dendritic spines in vivo by post synaptic density 95 protein (PSD-95)
Vickers, C. A., Stephens, B., Bowen, J., Arbuthnott, G. W., Grant, S. G. N., & Ingham, C. A. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.075 · Cited by 90
Self-citationStriatal Spine Plasticity in Parkinson's Disease
Villalba, R. M., & Smith, Y. (2010) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2010.00133 · Cited by 88
Dopamine Modulation of GABA Tonic Conductance in Striatal Output Neurons
Janssen, M. J., Ade, K. K., Fu, Z., & Vicini, S. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4737-08.2009 · Cited by 76
“Although these two cell types have similar basic physiological properties (Venance and Glowinski, 2003; Day et al., 2006; Taverna et al., 2008), we recently reported that D2 MSNs have greater GABAA receptor-mediated tonic conductance than D1 MSNs (Ade et al., 2008).”
BackgroundResultDu, K., Wu, Y., Lindroos, R., Liu, Y., Rózsa, B. J., Katona, G., Ding, J., & Kotaleski, J. H. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704893114 · Cited by 79
“The dendritic Na channel boosts the integration of inputs (1, 48) and favors action potential backpropagation (51).”
BackgroundSelf-citationCompartmental function and modulation of the striatum
Prager, E. M., & Plotkin, J. L. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24522 · Cited by 90
Striatal synaptic adaptations in Parkinson's disease
Shen, W., Zhai, S., & Surmeier, D. J. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105686 · Cited by 81
Self-citationEndocannabinoid–Dopamine Interactions in Striatal Synaptic Plasticity
Mathur, B. N., & Lovinger, D. M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00066 · Cited by 81
“The Surmeier laboratory elegantly showed that this dendritic pruning is restricted to indirect MSNs (Day et al., 2006).”
BackgroundKabir, Z. D., Lee, A. S., & Rajadhyaksha, A. M. (2016) · The Journal of Physiology · doi:10.1113/jp270673 · Cited by 83
“3 serving as the primary LTCC in the midbrain (Rajadhyaksha et al. 2004; Day et al. 2006).”
BackgroundInsights into Parkinson’s disease from computational models of the basal ganglia
Humphries, M. D., Obeso, J. A., & Dreyer, J. K. (2018) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-315922 · Cited by 83
Ma, Y., Cepeda, C., Chatta, P., Franklin, L., Evans, C. J., & Levine, M. S. (2012) · ASN NEURO · doi:10.1042/an20110063 · Cited by 79
“Key words: D1/D2 receptors, electrophysiology, nucleus accumbens, opioid receptors, striatum.”
BackgroundFasano, C., Bourque, M.-J., Lapointe, G., Leo, D., Thibault, D., Haber, M., Kortleven, C., DesGroseillers, L., Murai, K. K., & Trudeau, L.-É. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.030 · Cited by 67
Crittenden, J. R., Cantuti‐Castelvetri, I., Saka, E., Keller-McGandy, C. E., Hernández, L. F., Kett, L. R., Young, A. B., Standaert, D. G., & Graybiel, A. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812822106 · Cited by 71
Villalba, R. M., & Smith, Y. (2010) · The Journal of Comparative Neurology · doi:10.1002/cne.22563 · Cited by 84
“…in vitro electrophysiological studies have suggested increased activity of the corticostriatal system in parkinsonism (Galarraga et al., 1987; Calabresi et al., 1996; Marti et al., 1999), although this issue appears to be more complex than originally thought (Day et al., 2006; Mallet et al. 2006).”
BackgroundNeurotransmission systems in Parkinson’s disease
Moghaddam, H. S., Zare-Shahabadi, A., Rahmani, F., & Rezaei, N. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0068 · Cited by 86
Changes to interneuron-driven striatal microcircuits in a rat model of Parkinson's disease
Salin, P., López, I. P., Kachidian, P., Barroso‐Chinea, P., Rico, A. J., Gómez-Bautista, V., Coulon, P., Goff, L. K., & Lanciego, J. L. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.03.006 · Cited by 77
“…changes in striatal glutamatergic input ontoMSNs reported previously (Ingham et al., 1998) and the specific loss of spines in striatopallidal MSNs (Day et al., 2006), our data point to the high degree of reorganization of the striatal network after dopamine loss, notably involving an enhanced…”
ResultAstrocyte Regulation of Synapse Formation, Maturation, and Elimination
Chung, W., Baldwin, K. T., & Allen, N. J. (2024) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041352 · Cited by 79
Uncoupling of dopaminergic and subthalamic stimulation: Life‐threatening DBS withdrawal syndrome
Reuter, S., Deuschl, G., Falk, D., Mehdorn, H. M., & Witt, K. (2015) · Movement Disorders · doi:10.1002/mds.26324 · Cited by 74
Sunico, C. R., González‐Forero, D., Domínguez-Vías, G., García‐Verdugo, J. M., & Moreno‐López, B. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3911-09.2010 · Cited by 75
“A selective elimination of glutamatergic synapses on striatopallidal neurons occurs in PD models (Day et al., 2006), a promising connection with what happens in adult nNOS-expressing motoneurons.”
BackgroundSarantseva, S., Timoshenko, S., Bolshakova, O., Karaseva, E., Rodin, D., Schwarzman, A. L., & Vitek, M. P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008191 · Cited by 70
“Furthermore, studies with transgenic animals recapitulated very similar early pathologic events for different disease models [9–12].”
The pathomechanisms underlying Parkinson's disease
Jellinger, K. A. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.877842 · Cited by 83
Tewari, A. K., Shevchuk, M. M., Sterling, J., et al. (2011) · British Journal of Urology · doi:10.1111/j.1464-410x.2011.10169.x · Cited by 70
Determinants of Synaptobrevin Regulation in Membranes
Siddiqui, T. J., Vites, O., Stein, A., Heintzmann, R., Jahn, R., & Fasshauer, D. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-01-0049 · Cited by 83
“Molecular Biology of the Cell Vol. 18, 2037–2046, June 2007”
BackgroundPIKfyve regulates CaV1.2 degradation and prevents excitotoxic cell death
Tsuruta, F., Green, E. M., Rousset, M., & Dolmetsch, R. E. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200903028 · Cited by 74
“2 levels could lead to cell death in Parkinson’s disease (Day et al., 2006; Chan et al., 2007).”
BackgroundMorphological changes of glutamatergic synapses in animal models of Parkinson’s disease
Villalba, R. M., Mathai, A., & Smith, Y. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00117 · Cited by 78
“3α1 channels on D2R-containing neurons appear to be particularly important in mediating the spine pruning on indirect striatofugal neurons in mice (Day et al., 2006; Deutch et al., 2007; Surmeier et al., 2007; Soderstrom et al., 2010; Fieblinger et al., 2014b).”
BackgroundInfluentialEffects of acute dopamine depletion on the electrophysiological properties of striatal neurons
Fino, É., Glowinski, J., & Venance, L. (2007) · Neuroscience Research · doi:10.1016/j.neures.2007.04.002 · Cited by 81
Kelly, S. M., Raudales, R., He, M., Lee, J. H., Kim, Y., Gibb, L. G., Wu, P., Matho, K., Osten, P., Graybiel, A. M., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.06.021 · Cited by 68
Striatal spine plasticity in Parkinson's disease: pathological or not?
Smith, Y., Villalba, R. M., & Raju, D. V. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70805-3 · Cited by 76
“However, there is some indication that calcium likely contributes to this plastic event (Segal et al., 2000; Sabatini et al., 2001; Oertner and Matus, 2005; Day et al., 2006; Deutch et al., 2007; Surmeier et al., 2007).”
InfluentialCommentary: Dopaminergic dysfunction in DYT1 dystonia
Wichmann, T. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.04.020 · Cited by 67
“Thus, striatal dopamine depletion in Parkinsonism is associated with long-term (and probably irreversible) anatomic changes, such as the loss of dendritic spines of striatal neurons (Ingham et al., 1998; Arbuthnott et al., 2000; Day et al., 2006).”
BackgroundNomura, T., Musial, T. F., Marshall, J. J., Zhu, Y., Remmers, C. L., Xu, J., Nicholson, D. A., & Contractor, A. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2893-16.2017 · Cited by 64
“Two-photon laser scanning microscopy (2PLSM) images of PV-positive FS interneurons in the barrel cortex were visualized using methods similar to those previously described (Day et al., 2006).”
MethodSurface Traffic of Dendritic Ca V 1.2 Calcium Channels in Hippocampal Neurons
Di Biase, V., Tuluc, P., Campiglio, M., Obermair, G. J., Heine, M., & Flucher, B. E. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2300-11.2011 · Cited by 66
“…L-type currents leading to global calcium signals have been implicated in neurodegenerative disease (Stanika et al., 2010), and blocking LTCCs effectively reduces neuronal cell death in stroke and Parkinson disease (Korenkov et al., 2000; Schurr, 2004; Day et al., 2006; Chan et al., 2007).”
BackgroundTargeting Neuronal Populations of the Striatum
Durieux, P. F., Schiffmann, S. N., & d’Exaerde, A. D. K. (2011) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2011.00040 · Cited by 76
Presynaptic Regulation of Dopamine Transmission in Schizophrenia
Lyon, G. J., Abi-Dargham, A., Moore, H., Lieberman, J. A., Javitch, J. A., & Sulzer, D. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp010 · Cited by 66
Cognitive impairment and dementia in patients with Parkinson disease.
Leverenz, J. B., Quinn, J. F., Zabetian, C. P., Zhang, J., Montine, K. S., & Montine, T. J. (2009) · PubMed · Cited by 93
Jenner, P. G. (2008) · Movement Disorders · doi:10.1002/mds.22022 · Cited by 66
Soderstrom, K. E., Meredith, G. E., Freeman, T. B., McGuire, S. O., Collier, T. J., Sortwell, C. E., Wu, Q., & Steece‐Collier, K. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.06.018 · Cited by 67
West, A. R., & Tseng, K. Y. (2011) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2011.00055 · Cited by 71
Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's disease
Francardo, V., Schmitz, Y., Sulzer, D., & Cenci, M. A. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.10.001 · Cited by 74
Andreska, T., Lüningschrör, P., & Sendtner, M. (2020) · Cell and Tissue Research · doi:10.1007/s00441-020-03224-7 · Cited by 80
“…has similar consequences as ablation of BDNF or TrkB. Dopamine depletion is known to cause massive spine loss on striatal neurons (Day et al. 2006; Deutch 2006; Deutch et al. 2007; Gerfen 2006; Ingham et al. 1989; Ingham et al. 1998; McNeill et al. 1988; Villalba et al. 2009; Villalba and…”
BackgroundSoderstrom, K. E., O’Malley, J. A., Levine, N. D., Sortwell, C. E., Collier, T. J., & Steece‐Collier, K. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07077.x · Cited by 64
“In a subset of dopamine-grafted rats, nimodipine treatment was used to prevent dendritic spine loss, as described previously (Day et al., 2006).”
BackgroundMethodInfluentialIndirect-pathway neurons lose their spines in Parkinson disease
Gerfen, C. R. (2006) · Nature Neuroscience · doi:10.1038/nn0206-157 · Cited by 73
Déjean, C., Nadjar, A., Moine, C. L., Bioulac, B. H., Gross, C. E., & Boraud, T. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.02.004 · Cited by 63
“It is extremely difficult to address this question in patients because (1) symptoms only appear once most dopaminergic neurons have disappeared and (2) network activity rearrangements might occur during pre-symptomatic phase as shown in animal models (Day et al., 2006).”
STEP61is a substrate of the E3 ligase parkin and is upregulated in Parkinson’s disease
Kurup, P. K., Xu, J., Videira, R. A., Ononenyi, C., Baltazar, G., Lombroso, P. J., & Nairn, A. C. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417423112 · Cited by 62
Tinaz, S., Lauro, P. M., Ghosh, P., Lungu, C., & Horovitz, S. G. (2016) · NeuroImage Clinical · doi:10.1016/j.nicl.2016.12.019 · Cited by 66
Cortico-basal ganglia plasticity in motor learning
Roth, R. H., & Ding, J. (2024) · Neuron · doi:10.1016/j.neuron.2024.06.014 · Cited by 85
“150 However, both D1R-expressing dSPNs and D2R-expressing iSPNs have reduced dendritic arborization in PD, leading to an overall decrease in the number of spines.”
Self-citationAbiria, S. A., & Colbran, R. J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06436.x · Cited by 61
Synaptic and cellular plasticity in Parkinson’s disease
Chu, H. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0371-0 · Cited by 78
“These findings from postmortem analysis of end-stage PD were subsequently confirmed in neurotoxinbased animal models of PD using either Golgi impregnation of fixed brains [37] or two-photon live-cell imaging [38, 39].”
Loss of Homeostasis in the Direct Pathway in a Mouse Model of Asymptomatic Parkinson's Disease
Escande, M. V., Taravini, I. R. E., Zold, C. L., Belforte, J. E., & Murer, M. G. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0492-15.2016 · Cited by 65
“Although some studies reported a decreased number of spines in dMSNs after 6-OHDA lesions (Villalba et al., 2009; Suárez et al., 2014; Toy et al., 2014), others did not find any differences in spine density (Day et al., 2006; Fieblinger et al., 2014).”
BackgroundCross-hemispheric dopamine projections have functional significance
Fox, M. E., Mikhailova, M. A., Bass, C. E., Takmakov, P. A., Gainetdinov, R. R., Budygin, E. A., & Wightman, R. M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603629113 · Cited by 70
Levodopa/dopamine replacement strategies in Parkinson's disease-Future directions
Olanow, C. W. (2008) · Movement Disorders · doi:10.1002/mds.22061 · Cited by 68
Review: Electrophysiology of Basal Ganglia and Cortex in Models of Parkinson Disease
Ellens, D. J., & Leventhal, D. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-130204 · Cited by 70
“Dendritic spines and glutamatergic synapses onto iMSNs are greatly diminished [19], though dMSN excitability is diminished and iMSN excitability enhanced to cortical stimulation [20].”
Aravamuthan, B. R., Bergstrom, D. A., French, R. A., Taylor, J. J., Parr‐Brownlie, L. C., & Walters, J. R. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.05.023 · Cited by 61
“…spines have been observed in 6-OHDA lesioned rats and transgenic mouse models of PD (Ingham et al., 1989, 1993, 1998; Day et al., 2006; Solis et al., 2007) and could be related to decreased connectivity and glutamatergic input to the striatum (McAllister, 2000; Day et al., 2006) from the cortex.”
BackgroundGhiglieri, V., Mineo, D., Vannelli, A., Cacace, F., Mancini, M., Pendolino, V., Napolitano, F., di Maio, A., Mellone, M., Stanic, J., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.11.022 · Cited by 58
Deng, Y., Lanciego, J. L., Goff, L. K., Coulon, P., Salin, P., Kachidian, P., Lei, W., Mar, N. D., & Reiner, A. J. (2015) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2015.00051 · Cited by 61
“Note that use of D1− immunolabeling to detect iSPNs has been employed by others as well (Day et al., 2006; Lei et al., 2013; Deng et al., 2014).”
MethodNeuroglial Plasticity at Striatal Glutamatergic Synapses in Parkinson's Disease
Villalba, R. M., & Smith, Y. (2011) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2011.00068 · Cited by 63
“…studies suggested an increased activity of the corticostriatal system in parkinsonism (Galarraga et al., 1987; Calabresi et al., 1996; Marti et al., 1999), though this issue remains controversial and appears to be more complex than originally thought (Day et al., 2006; Mallet et al., 2006).”
How voltage-gated calcium channels gate forms of homeostatic synaptic plasticity
Frank, C. A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00040 · Cited by 57
“In MSNs, increased striatal dopamine causes an increase in MSN spine density (Kim et al., 2009).”
BackgroundSplice variants of the CaV1.3 L-type calcium channel regulate dendritic spine morphology
Stanika, R. I., Campiglio, M., Pinggera, A., Lee, A., Striessnig, J., Flucher, B. E., & Obermair, G. J. (2016) · Scientific Reports · doi:10.1038/srep34528 · Cited by 61
“14; reviewed in ref.”
InfluentialMolecular Mechanisms of l-DOPA-Induced Dyskinesia
Fisone, G., & Bézard, E. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-381328-2.00004-3 · Cited by 71
Sconce, M. D., Churchill, M. J., Greene, R. E., & Meshul, C. K. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.04.069 · Cited by 59
Marcantoni, A., Carabelli, V., Vandael, D. H. F., Comunanza, V., & Carbone, E. (2008) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-008-0584-4 · Cited by 60
Willard, A. M., Isett, B. R., Whalen, T. C., Mastro, K. J., Ki, C. S., Mao, X., & Gittis, A. H. (2019) · eLife · doi:10.7554/elife.42746 · Cited by 59
“, 2002), synaptic and intrinsic changes within the striatum (Blesa et al., 2012; Day et al., 2006; Escande et al., 2016; Fieblinger et al., 2014; Fuller et al., 2014; Gittis et al., 2011; Taverna et al., 2008), and plasticity in the GPe/STN (Chu et al.”
BackgroundGene therapy for Parkinson's disease
Björklund, T., & Kordower, J. H. (2010) · Movement Disorders · doi:10.1002/mds.22785 · Cited by 64
Damodaran, S., Evans, R. C., & Blackwell, K. T. (2013) · Journal of Neurophysiology · doi:10.1152/jn.00382.2013 · Cited by 64
Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson’s Disease?
Schulz‐Schaeffer, W. (2015) · Biomolecules · doi:10.3390/biom5031467 · Cited by 62
“using the 6-hydroxy dopamine model of Parkinson’s disease [52,53] or in reserpine-treated mice [54], as well as in the striatal regions and the substantia nigra in human Parkinson’s disease tissues [14,55–58].”
MethodFuture of cell and gene therapies for Parkinson's disease
Isacson, O., & Kordower, J. H. (2009) · Annals of Neurology · doi:10.1002/ana.21473 · Cited by 61
Molecular Profiling of Striatonigral and Striatopallidal Medium Spiny Neurons
Lobo, M. K. (2009) · International review of neurobiology · doi:10.1016/s0074-7742(09)89001-6 · Cited by 62
“Nonetheless, it is important to note that many insights into differential electrophysiological properties including synaptic plasticity, DA modulation, cholinergic modulation, intrinsic excitability, glutamatergic activity, and GABA activity have been made using these mice (Ade et al., 2008; Cepeda et al., 2008; Day e…”
BackgroundMethodInfluentialAstrocytosis in parkinsonism: considering tripartite striatal synapses in physiopathology?
Charron, G., Doudnikoff, E., Canron, M.-H., Li, Q., Véga, C., Marais, S., Baufreton, J., Vital, A., Oliet, S. H. R., & Bezard, E. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00258 · Cited by 53
“…synapses decrease in 6-OHDA rats compared with controls (Figure 4C), a result in agreement with literature in the 6-OHDA rat (Ingham et al., 1989; Day et al., 2006; Scholz et al., 2008; Schuster et al., 2009; Donnelly et al., 2013; Suárez et al., 2014) and in the MPTP-treated macaque monkey…”
BackgroundResultInfluentialGender and manganese exposure interactions on mouse striatal neuron morphology
Madison, J. L., Węgrzynowicz, M., Aschner, M., & Bowman, A. B. (2011) · NeuroToxicology · doi:10.1016/j.neuro.2011.05.007 · Cited by 55
“In PD, the pigmented DAergic neurons of the SN degenerate resulting in damage to striatal medium spiny neurons (MSN) (Day et al., 2006; Garcia et al., 2010; Wright et al., 2009; Zaja-Milatovic et al., 2005).”
Naskar, A., Manivasagam, T., Chakraborty, J., Singh, R. P., Thomas, B., Dhanasekaran, M., & Mohanakumar, K. P. (2013) · Journal of Pineal Research · doi:10.1111/jpi.12076 · Cited by 53
“3 L-type Ca channels and opening of NMDA receptors leading to excessive intraspine calcium influx in these neurons, culminating in spine damage, and its lesioning [7, 9].”
BackgroundLevodopa treatment and dendritic spine pathology
Nishijima, H., Ueno, T., Funamizu, Y., Ueno, S., & Tomiyama, M. (2017) · Movement Disorders · doi:10.1002/mds.27172 · Cited by 55
“In reserpine-treated PD model mice, it was found that iSPNs lost dendritic spines, whereas dSPNs did not.(43) Shen and colleagues(44) reported substantial pruning of spines and glutamatergic synapses in iSPNs, leaving dSPNs intact in PD model mice.”
BackgroundUlusoy, A., Şahin, G., & Kirik, D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003432107 · Cited by 56
Walker, R. H., Moore, C., Davies, G., Dirling, L. B., Koch, R. J., & Meshul, C. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032919 · Cited by 53
“Some studies have found evidence for spine loss only on D2 receptor-bearing striatopallidal neurons which comprise the indirect pathway [32].”
BackgroundIbáñez-Sandoval, O., Carrillo‐Reid, L., Galarraga, E., Tapia, D., Mendoza, E., Gómora, J. C., Aceves, J., & Bargas, J. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00620.2007 · Cited by 55
A pathoconnectome of early neurodegeneration: Network changes in retinal degeneration
Pfeiffer, R. L., Anderson, J. R., Dahal, J., García, J. C. G., Yang, J., Sigulinsky, C., Rapp, K. D., Emrich, D. P., Watt, C. B., Johnstun, H. A., et al. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.108196 · Cited by 53
Deutch, A. Y. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_12 · Cited by 55
Self-citationDendritic and Synaptic Protection: Is It Enough to Save the Retinal Ganglion Cell Body and Axon?
Morquette, J. B., & Di Polo, A. (2008) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0b013e318177edf0 · Cited by 51
Kusnoor, S. V., Parris, J., Muly, E. C., Morgan, J. I., & Deutch, A. Y. (2010) · Journal of Comparative Neurology · doi:10.1002/cne.22350 · Cited by 51
Self-citationLong-Lasting NMDA Receptor-Mediated EPSCs in Mouse Striatal Medium Spiny Neurons
Logan, S. M., Partridge, J. G., Matta, J. A., Buonanno, A., & Vicini, S. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00462.2007 · Cited by 51
The missing, the short, and the long: Levodopa responses and dopamine actions
Albin, R. L., & Leventhal, D. (2017) · Annals of Neurology · doi:10.1002/ana.24961 · Cited by 55
Mathar, D., Neumann, J., Villringer, A., & Horstmann, A. (2017) · Cortex · doi:10.1016/j.cortex.2017.08.022 · Cited by 58
Loss of nigral excitation of cholinergic interneurons contributes to parkinsonian motor impairments
Cai, Y., Nielsen, B. E., Boxer, E. E., Aoto, J. N., & Ford, C. (2021) · Neuron · doi:10.1016/j.neuron.2021.01.028 · Cited by 56
Calin‐Jageman, I. E., Yu, K., Hall, R. A., Mei, L., & Lee, A. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.5191-06.2007 · Cited by 50
“3 activation selectively causes depression-like behavior (Sinnegger-Brauns et al., 2004), promotes synaptic changes associated with Parkinson’s disease (Day et al., 2006), and is essential for auditory transduction (Platzer et al., 2000; Dou et al., 2004).”
BackgroundMohanan, A. G., Gunasekaran, S., Jacob, R. S., & Omkumar, R. V. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.855752 · Cited by 55
Linking α-synuclein-induced synaptopathy and neural network dysfunction in early Parkinson’s disease
Kulkarni, A. S., Burns, M. R., Brundin, P., & Wesson, D. W. (2022) · Brain Communications · doi:10.1093/braincomms/fcac165 · Cited by 49
“as demonstrated in some recent Parkinson’s disease models.(120,219) When neural activity is perturbed for a sustained”
BackgroundDeng, Y., Wong, T., Wan, J. Y., & Reiner, A. J. (2014) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2014.00198 · Cited by 59
“As in prior studies by us and others, we used D1 immunolabeling to distinguish dSPN spines and dendrites (D1–positive) from iSPN spines and dendrites (D1–negative) (Day et al., 2006; Lei et al., 2013).”
ResultSingh, A. P., Liang, L., Kaneoke, Y., Cao, X., & Papa, S. M. (2014) · Journal of Neurophysiology · doi:10.1152/jn.00910.2014 · Cited by 51
“Morphological and physiological studies have shown alterations of MSN dendritic terminals and changes in synaptic plasticity (Calabresi et al. 2014; Day et al. 2006).”
BackgroundSpigolon, G., & Fisone, G. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1847-7 · Cited by 56
Graves, S. M., & Surmeier, D. J. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00032 · Cited by 49
Self-citationTargeting the cholinergic system in Parkinson’s disease
Liu, C. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0380-z · Cited by 58
Klug, J. R., Mathur, B. N., Kash, T. L., Wang, H.-D., Matthews, R. T., Robison, A. J., Anderson, M. E., Deutch, A. Y., Lovinger, D. M., Colbran, R. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045323 · Cited by 49
“[65,66,67,68], although this is not always the case [69].”
Self-citationPancani, T., Foster, D. J., Moehle, M. S., Bichell, T. J., Bradley, E. M., Bridges, T. M., Klar, R., Poslusney, M., Rook, J. M., Daniels, J. S., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1512812112 · Cited by 51
“Moreover, loss of striatal DA activity seen in symptomatic animals has been associated with aberrant plasticity (45), alterations of dendritic spines, and also alteration of glutamatergic signaling (46, 47).”
BackgroundKnock-In Rat Lines with Cre Recombinase at the Dopamine D1 and Adenosine 2a Receptor Loci
Pettibone, J. R., Yu, J. Y., Derman, R. C., Faust, T. W., Hughes, E. D., Filipiak, W. E., Saunders, T. L., Ferrario, C. R., & Berke, J. D. (2019) · eNeuro · doi:10.1523/eneuro.0163-19.2019 · Cited by 51
“These mice have also been widely used for identification of dMSNs versus iMSNs in brain slice experiments (Day et al., 2006).”
BackgroundMethodPathway-specific dysregulation of striatal excitatory synapses by LRRK2 mutations
Chen, C., Soto, G., Dumrongprechachan, V., Bannon, N., Kang, S., Kozorovitskiy, Y., & Parisiadou, L. (2020) · eLife · doi:10.7554/elife.58997 · Cited by 56
“While there is evidence that at first iSPNs show the primary structural and functional synaptic and dendritic changes in response to dopamine loss (Gerfen, 2006; Gertler et al., 2008; Day et al., 2006; Villalba et al., 2009), with time both SPNs types undergo substantial adaptations (Suarez et al.”
BackgroundHow do adenosine A2A receptors regulate motor function?
Mori, A. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.09.025 · Cited by 51
Ghaisas, S., Langley, M. R., Palanisamy, B. N., Dutta, S., Narayanaswamy, K., Plummer, P. J., Sarkar, S., Ay, M., Jin, H., Anantharam, V., et al. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.09.004 · Cited by 49
“Also, the loss of innervating dopaminergic neurons in the striatum in PD alters the complex DARPP-32 signaling cascade, resulting in abnormal firing patterns and subsequent motor dysfunction (Brown, 2003; Day et al., 2006).”
BackgroundWillard, A. M., Bouchard, R. S., & Gittis, A. H. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.068 · Cited by 53
New synaptic and molecular targets for neuroprotection in Parkinson's disease
Calabresi, P., Filippo, M. D., Gallina, A., Wang, Y., Stankowski, J. N., Picconi, B., Dawson, V. L., & Dawson, T. M. (2012) · Movement Disorders · doi:10.1002/mds.25096 · Cited by 50
Thinking Outside the Box (and Arrow): Current Themes in Striatal Dysfunction in Movement Disorders
Plotkin, J. L., & Goldberg, J. A. (2018) · The Neuroscientist · doi:10.1177/1073858418807887 · Cited by 52
Krajeski, R. N., Macey-Dare, A. D. B., van Heusden, F., Ebrahimjee, F., & Ellender, T. J. (2019) · The Journal of Physiology · doi:10.1113/jp278416 · Cited by 53
Metadata
- Authors
- Day, M., Wang, Z., Ding, J., An, X., Ingham, C. A., Shering, A. F., Wokosin, D., Ilijic, E., Sun, Z., Sampson, A. R., Mugnaini, E., Deutch, A. Y., Sesack, S. R., Arbuthnott, G. W., & Surmeier, D. J.
- Affiliations
- Northwestern University (US)
- University of Pittsburgh (US)
- University of Edinburgh (GB)
- Vanderbilt University Medical Center (US)
- Corresponding author
- Surmeier, D James
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2006-01-15
- Volume
- 9
- Issue
- 2
- Pages
- 251-259
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2127235616
- Semantic Scholar
- f5053a014f262e9d424b82f7536ce2f320899a27
- Cited by
- 745
- References
- 52
- Citations by year
- 2026: 5 · 2025: 22 · 2024: 18 · 2023: 21 · 2022: 30 · 2021: 22 · 2020: 29 · 2019: 31 · 2018: 31 · 2017: 36 · 2016: 45 · 2015: 42 · 2014: 38 · 2013: 35 · 2012: 39
- FWCI
- 41.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- National Institutes of Health (5p01ns044282-05)
- National Institute of Neurological Disorders and Stroke (NS 19608, NS 34696, NS 44282, NS047085, P50NS047085)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- Parkinson's disease, striatopallidal neurons, medium spiny neurons, glutamatergic synapses, dendritic spine loss, dopamine depletion, striatonigral neurons, Cav1.3 L-type calcium channel, motor command, striatum
- MeSH terms
- Animals, Corpus Striatum, Disease Models, Animal, Glutamine, Mice, Inbred C57BL, Neural Pathways, Organ Culture Techniques, Parkinson Disease, Synapses, Microscopy, Immunoelectron, Patch-Clamp Techniques, Reverse Transcriptase Polymerase Chain Reaction, Calcium Channels, L-Type, Dendritic Spines, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.